Brandtree

Who owns MiniMed?

MiniMed is owned by Medtronic (Ireland, NYSE: MDT).[1]

Medtronic owns 90.03% of MiniMed rather than all of it.

Evidence: Medtronic plc Annual Report on Form 10-K filed 2026-06-18, SEC EDGAR, 18 June 2026. Verified from filings; last checked .

Key facts

Current owner
Medtronic plc (90.03% stake) verified
Owner HQ
🇮🇪 Ireland, Galway
Origin
🇺🇸 United States
Category
Healthcare & pharma › Devices & animal health › Medical devices
Parent ticker
NYSE: MDT
Last verified
· 1 sources

About MiniMed

MiniMed Group, Inc. holds Medtronic's diabetes business. It completed an initial public offering on March 9, 2026 in which about 10% of its ownership was sold, and Medtronic reported owning 252,813,348 MiniMed shares, about 90.03%, and consolidating it. The 10-K says Medtronic intends to complete the separation.

How often Medtronic names MiniMed in its annual report

A plain count of the times the name appears in the text of each annual report, not counting the start of a sentence. A brand that an owner writes about more is usually one it treats as central. The brand is named more often than it was three years earlier.

Annual report filedTimes MiniMed is named
202677
20257
20247

Ownership timeline of MiniMed

  1. Current owner Medtronic (90.03%) [1] verified

Where MiniMed sits in Medtronic

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Where MiniMed sits in Medtronic Tree of 3 brands under Medtronic. Medtronic MiniMed 90.03% Hugo RAS Micra

Open the full Medtronic ownership tree →

See the full Medtronic brand portfolio (3) →

Other brands owned by Medtronic

Medtronic controls 3 brands on Brandtree, 3 of them in healthcare & pharma.

Also in healthcare & pharma

All Medtronic brands →

Other brands in devices & animal health, and who owns them

The 11 brands in devices & animal health on Brandtree belong to 3 owners. The largest is Neogen, with 5.

BrandOwnerOwner based in
IDEXX Catalyst One IDEXX 🇺🇸 United States
BotVax B Neogen 🇺🇸 United States
IDEXX inVue Dx IDEXX 🇺🇸 United States
IDEXX ProCyte One IDEXX 🇺🇸 United States
IDEXX SediVue Dx IDEXX 🇺🇸 United States
IDEXX SNAP IDEXX 🇺🇸 United States
Ideal Neogen 🇺🇸 United States
Prima Tech Neogen 🇺🇸 United States

Every brand in devices & animal health and its owner →

About the owner: Medtronic

Medtronic is a publicly listed company headquartered in Galway, Ireland, founded in 1949. Brandtree records 3 brands under its control, and it is listed as NYSE: MDT.

Medtronic plc says it was founded in 1949 and is headquartered in Galway, Ireland. Its fiscal 2026 annual report describes three reportable segments, the Cardiovascular, Neuroscience and Medical Surgical portfolios, and a Diabetes business that is being separated as MiniMed Group, Inc.

Medtronic: full profile, brands and acquisition history →

🇺🇸 MiniMed and other American brands

Brandtree records a controlling owner for 2,399 brands that began in the United States. 461 of them (19%) are now controlled by a company headquartered in another country, MiniMed among them.

All American brands and who owns them →

Frequently asked questions

Who is the parent company of MiniMed?

The parent company of MiniMed is Medtronic, a publicly listed company headquartered in Ireland.

Is MiniMed American or Irish?

MiniMed originated in the United States, but it is owned today by Medtronic, which is headquartered in Ireland. So MiniMed is an American-origin brand under Irish ownership.

Is MiniMed still owned by Medtronic?

Yes. As of 9 October 2026, MiniMed is still owned by Medtronic (90.03% stake). The ownership record was last checked against primary sources on that date.

Sources (1) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] Medtronic plc Annual Report on Form 10-K filed 2026-06-18 — SEC EDGAR, SEC Form 10-K, published 18 June 2026; retrieved 9 October 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.